Gritse

Gritse is a prescription oral medication that contains the corticosteroid dexamethasone as its active ingredient. It is marketed in the European Union and is supplied in tablet form, though specific strength information is not disclosed. Dexamethasone belongs to the glucocorticoid class and works by binding to intracellular receptors to modify gene expression, providing anti‑inflammatory and immunosuppressive effects. It is typically prescribed by healthcare professionals for conditions requiring systemic inflammation control.

Gritse (dexamethasone) is used in a variety of inflammatory and immune‑mediated conditions where systemic glucocorticoid therapy is indicated.

- Management of acute and chronic inflammatory disorders such as rheumatoid arthritis. - Treatment of severe allergic reactions, including anaphylaxis adjunct therapy. - Control of asthma exacerbations and other respiratory inflammatory conditions. - Therapy for dermatologic diseases that respond to systemic steroids, e.g., severe eczema or psoriasis. - Adjunctive treatment for certain oncologic protocols to reduce chemotherapy‑induced inflammation.

Side effects of dexamethasone may vary in frequency and severity, reflecting its broad immunomodulatory activity.

Common: - Increased appetite or weight gain. - Elevated blood glucose levels. - Mood changes such as irritability or euphoria. - Gastrointestinal discomfort, including nausea or abdominal pain.

Serious: - Suppression of the hypothalamic‑pituitary‑adrenal (HPA) axis leading to adrenal insufficiency. - Severe infections due to immune suppression. - Osteoporosis or increased risk of fractures with long‑term use.

When prescribing Gritse, clinicians consider several precautions to minimize risks and ensure safe therapy.

- Assess for active or latent infections before initiating treatment. - Monitor blood glucose in diabetic patients or those at risk for hyperglycemia. - Use the lowest effective dose for the shortest duration to reduce adrenal suppression. - Evaluate bone health, especially in patients with osteoporosis risk factors. - Consider potential effects on pregnancy and lactation; use only if benefits outweigh risks. - Review patient history for psychiatric disorders, as steroids can exacerbate mood symptoms.

Dexamethasone can interact with other medicines, altering their effectiveness or increasing adverse effects.

Avoid: - Strong CYP3A4 inducers such as rifampin, phenytoin, or carbamazepine, which may reduce dexamethasone levels. - Live vaccines, because immunosuppression can diminish vaccine efficacy.

Use with caution: - Anticoagulants (e.g., warfarin) as steroids may enhance anticoagulant effect. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) because combined use raises risk of gastrointestinal ulceration. - Antidiabetic agents, since dexamethasone can increase blood glucose and may require dose adjustment.